Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at Wall Stre
Kalaris Therapeutics, Inc. (KLRS)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
KLRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLRS alerts
High impacting Kalaris Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
KLRS
News
- Kalaris Reports Third Quarter 2025 Financial Results and Provides Business UpdatesGlobeNewswire
- Kalaris Therapeutics (NASDAQ:KLRS) is now covered by analysts at Citizens Jmp. They set a "mkt outperform" rating and a $20.00 price target on the stock.MarketBeat
- Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial OfficerGlobeNewswire
- Kalaris Therapeutics (NASDAQ:KLRS) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.MarketBeat
- Kalaris to Present at Stifel 2025 Annual Healthcare ConferenceGlobeNewswire
KLRS
Earnings
- 5/14/25 - Miss
KLRS
Analyst Actions
- 11/3/25 - Citigroup Inc.